S. Buckley

Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep

C. Rodeck, D. Peebles, A. David, 2008, Gene Therapy.

The hopes and fears of in utero gene therapy for genetic disease--a review.

C. Rodeck, D. Peebles, A. David, 2003, Placenta.

In utero administration of Ad5 and AAV pseudotypes to the fetal brain leads to efficient, widespread and long-term gene expression

J. Cooper, A. Baker, A. Rahim, 2011, Gene Therapy.

Fetal and neonatal gene therapy: benefits and pitfalls

C. Coutelle, M. Themis, S. Waddington, 2004, Gene therapy.

Genetic aspects and research development in haemostasis

G. Mariani, S. Waddington, F. Peyvandi, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

The current status and future directions of fetal gene therapy

C. Rodeck, D. Peebles, A. David, 2003 .

Erratum: Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep (Gene Therapy (2008) vol. 15 (1344-1350) 10.1038/sj.gt.2008.102)

Wigley, C. Rodeck, D. Peebles, 2008 .

Oncogenesis following delivery of a non-primate lentiviral gene therapy vector to fetal mice

Simon N. Waddington, Michael Themis, Manfred Schmidt, 2005 .

Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep

C. Rodeck, D. Peebles, A. David, 2008, Gene Therapy.

Reduced toxicity of F-deficient Sendai virus vector in the mouse fetus

C. Coutelle, G. Ungerechts, S. Bossow, 2004, Gene Therapy.